EUVIMEDEUVIMED entdecken
Crossref

Fluoroquinolone-Related Neuropsychiatric Events in Hospitalized Veterans

John Sellick, Kari Mergenhagen, Lindsay Morris, Lindsey Feuz, Amy Horey, Vineeta Risbood, Amy Wojciechowski, Christine Ruh, Edward Bednarczyk, Erin Conway, Michael Ott

Psychosomatics · 2018-05 · 59 (3) · 259-266

DOI: 10.1016/j.psym.2017.11.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Psychosomatics, 2018-05. Verfasst von John Sellick und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Jacobs School of Medicine & Biomedical Sciences, University at Buffalo School of Medicine and Biomedical Sciences, Infectious…. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To measure the incidence and risk factors for fluoroquinolone (ciprofloxacin, moxifloxacin, and levofloxacin)-associated psychosis or delirium in a veteran population. METHODS: A retrospective study was conducted in the Western New York Veterans Affairs Health System (2005-2013). Participants were hospitalized veterans receiving a fluoroquinolone for at least 48 hours (n = 631). Cases of delirium or psychosis were defined by the Diagnostic and Statistical Manual of Mental Disorders-IV criteria, and the Naranjo scale (score ≥ 1) was used to determine the probability of the adverse drug reaction being related to fluoroquinolones. A bivariate analysis of covariates followed by a multivariate logistic regression was used to determine predisposing factors to the development of delirium/psychosis. RESULTS: The mean age of the population was 71.5 years (range: 22-95). Fluoroquinolone-associated delirium/psychosis occurred in 3.7% of the inpatients studied (n = 23). The median Naranjo score was 3 indicating a possible association. Psychosis/delirium occurred in 3.6% of ciprofloxacin-treated patients (n = 14/391), 4.5% of patients-treated with moxifloxacin (n = 9/200), and 0% of those receiving levofloxacin (n = 0/40); p = 0.4. Significant risk factors for development of delirium/psychosis in patients receiving a fluoroquinolone in the multivariate logistical regression included typical antipsychotic use (OR, 5.4; 95% CI: 1.4-16.7) and age. A 10-year increase in age was associated with a 1.8-fold greater odds of a neuropsychiatric event. CONCLUSIONS: Fluoroquinolones may be more commonly associated with delirium/psychosis than originally reported in this veteran population. Caution should be used when prescribing a fluoroquinolone for patients on typical antipsychotics and those of advanced age.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdultAge FactorsAgedAged, 80 and overAnti-Bacterial AgentsAntipsychotic AgentsCiprofloxacinDeliriumFemaleFluoroquinolonesHospitalizationHumansLevofloxacinLogistic ModelsMaleMiddle AgedMoxifloxacinMultivariate AnalysisNew YorkOdds Ratio

Stichwörter der Autor:innen

Adverse Drug EventsAntibioticsDrug SafetyFluoroquinolonesInfectious DiseasesMedication Safety

Substanzen

Anti-Bacterial AgentsAntipsychotic AgentsFluoroquinolonesCiprofloxacinLevofloxacinMoxifloxacin

Autor:innen und Institutionen

  • Department of Medicine, Jacobs School of Medicine & Biomedical Sciences, University at Buffalo School of Medicine and Biomedical Sciences, Infectious Diseases, Buffalo, NY; Department of Infectious Diseases, VA Western…
  • Department of pharmacy, VA Western New York Healthcare System, Buffalo VA Medical Center, Pharmacy, Buffalo, NY. Electronic address: kari.mergenhagen@va.gov.
  • Department of pharmacy, VA Western New York Healthcare System, Buffalo VA Medical Center, Pharmacy, Buffalo, NY; Department of Defense, Landstuhl Regional Medical Center, Pharmacy, Landstuhl, Germany.
  • Department of pharmacy, VA Western New York Healthcare System, Buffalo VA Medical Center, Pharmacy, Buffalo, NY; Department of Pharmacy, Buffalo General Medical Center, Pharmacy, Buffalo, NY.
  • Department of pharmacy, VA Western New York Healthcare System, Buffalo VA Medical Center, Pharmacy, Buffalo, NY.
  • Department of Pharmacy, D'Youville College, School of Pharmacy, Buffalo, NY.

Zitieren

APA

Sellick, J., Mergenhagen, K., Morris, L., Feuz, L., Horey, A., Risbood, V., Wojciechowski, A., Ruh, C., Bednarczyk, E., Conway, E., & Ott, M. (2018). Fluoroquinolone-Related Neuropsychiatric Events in Hospitalized Veterans. Psychosomatics, 59(3), 259-266. https://doi.org/10.1016/j.psym.2017.11.001

Vancouver

Sellick J, Mergenhagen K, Morris L, Feuz L, Horey A, Risbood V, et al. Fluoroquinolone-Related Neuropsychiatric Events in Hospitalized Veterans. Psychosomatics. 2018;59(3):259-266. doi:10.1016/j.psym.2017.11.001

BibTeX
@article{Sellick2018,
  author = {Sellick, John and Mergenhagen, Kari and Morris, Lindsay and Feuz, Lindsey and Horey, Amy and Risbood, Vineeta and Wojciechowski, Amy and Ruh, Christine and Bednarczyk, Edward and Conway, Erin and Ott, Michael},
  title = {Fluoroquinolone-Related Neuropsychiatric Events in Hospitalized Veterans},
  journal = {Psychosomatics},
  year = {2018},
  volume = {59},
  number = {3},
  pages = {259--266},
  doi = {10.1016/j.psym.2017.11.001}
}
Kostenlos starten →